Lenticular Research Group

Naperville, United States Founded: 2007 • Age: 19 yrs
Developer of laser device for treating the cause of presbyopia

About Lenticular Research Group

Lenticular Research Group is a Healthcare company based in Naperville (United States) founded in 2007 by George J McArdle. Developer of laser device for treating the cause of presbyopia. Lenticular Research Group has raised $330 thousand across 1 funding round. Its chief executive, as recorded, is George J McArdle. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Lenticular Research Group, LLC. Its competitors include Clerio Vision and IntraLase; 2 of its 2 listed competitors have raised funding.

Company details

Lenticular Research Group has developed a laser device for treating presbyopia. The laser device is used for targeted therapy to the germinative zone of the crystalline lens to inhibit inhibits epithelial cell reproduction to arrest the progression of presbyopia in the early stage.

  • Headquarters Naperville, United States
  • Founders George J McArdle
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lenticularresearchgroup.com
  • Legal Name Lenticular Research Group, Llc
Operational Areas
Key Metrics
  • Total Equity Funding
    $330K (USD)

    in 1 rounds

  • Latest Funding Round
    $330K (USD), Seed

    Aug 2015

Funding Insights of Lenticular Research Group

Lenticular Research Group has successfully raised a total of $330K through 1 strategic funding round. The most recent funding activity was a Seed round of $330 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $330,000
  • Total Rounds 1
  • Last Round Seed β€” $330,000
  • First Round $330,000

    (Aug 2015)

All 1 funding rounds of Lenticular Research Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2015$330,000Seed––
–

People of Lenticular Research Group

9 people are tracked at Lenticular Research Group (1 in leadership, 7 in board & advisors, 1 in team).

NameRoleGroup
George J McArdle
Founder & CEOLeadership
Richard L. Lindstrom
AdvisorBoard & advisors
Roger Steinert
AdvisorBoard & advisors
Daniel S. Durrie
AdvisorBoard & advisors
Vance Thompson
AdvisorBoard & advisors
William B. Trattler
AdvisorBoard & advisors
Louis Probst
AdvisorBoard & advisors
Steve Schallhorn
AdvisorBoard & advisors
Rebecca Zoltoski
Research Team LeadTeam
Premium access

Complete people profiles for Lenticular Research Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Lenticular Research Group

2 dated milestones of Lenticular Research Group across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lenticular Research Group is founded.
  2. Funding First funding round of $330K.

Competitors of Lenticular Research Group

Lenticular Research Group has 2 listed competitors in our database, 2 of them funded. They include Clerio Vision and IntraLase.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cleriovision.com2014Rochester, United States$28.95M90
Laser induced change in refractive index
intralase.com1997Irvine, United States$29.5M
Femtosecond laser technology is developed for eye surgery procedures.
Premium access

Detailed competitors of Lenticular Research Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

3 companies that operate in the same segment as Lenticular Research Group (Ophthalmology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 24.69 B25,941
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Lenticular Research Group

Lenticular Research Group was founded in 2007 and raised its 1st funding round 8 years after it was founded.

Lenticular Research Group is headquartered in Naperville, United States. It is registered at Naperville, Illinois, United States.

George J McArdle is the CEO of Lenticular Research Group, as recorded in our data. They have also founded this company.

Lenticular Research Group is a funded company, having raised a total of $330K across 1 funding round to date. The company's 1st funding round was a Seed of $330K, raised on Aug 2015.

Lenticular Research Group has developed a laser device for treating presbyopia. The laser device is used for targeted therapy to the germinative zone of the crystalline lens to inhibit inhibits epithelial cell reproduction to arrest the progression of presbyopia in the early stage.

Lenticular Research Group's top competitors include Clerio Vision and IntraLase.

Lenticular Research Group operates through Lenticular Research Group, Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available